Sabinsa, the leading nutraceutical ingredients company with patents throughout the world, has expanded its portfolio of intellectual property with a new patent granted in Mexico for Saberry®.
- Details
- Press Release
- Details
- Press Release
A clinical study on Sabinsa’s patented hair serum formulation was found to significantly improve hair fall and thinning. “Clinical Study to Evaluate the Efficacy and Safety of a Hair Serum Product in Healthy Adult Male and Female Volunteers with Hair Fall” by Majeed M, Majeed S, Nagabhushanam K, Mundkur L, Neupane P and Shah K was published in Clinical, Cosmetic and Investigational Dermatology (2020:13 691–700).
- Details
- Press Release
Additional In Vitro Study Examined Anti-Aging Properties
As Sabinsa’s R&D Scientists expanded their understanding of probiotics, and developed new products based upon that increased knowledge, it was inevitable that published studies would soon follow. Sabinsa has recently published its first human clinical study on anti-acne benefits of LactoSporin®, the probiotic metabolite derived from the highly regarded probiotic LactoSpore®. A second published study, in vitro, demonstrated the anti-aging potential of this topical ingredient. Together, the research supports the use of LactoSporin for skin care applications.
- Details
- Press Release
Sabinsa has sent a cease & desist letter to Applied Food Sciences (AFS) for making claims of high levels of natural vitamin C in that company’s branded amla (Emblica officinalis) extract. The letter states that AFS’s representations that the product contains 25% vitamin C derived from amla (which is not technically possible) “mislead and deceive consumers and constitute unfair competition and false advertising under applicable law.”
- Details
- Press Release
Sabinsa, the pioneer of ingredients conceived by modern science drawing from traditional Ayurvedic knowledge, announces a new combination to support healthy liver function, LivLonga®, giving a boost to a category teeming with dated, generic products.